Sawai Pharmaceutical Co Ltd (4555) – Strategy, SWOT and Corporate Finance Report

Sawai Pharmaceutical Co Ltd (4555) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.

Scope

• Detailed information on Sawai Pharmaceutical Co Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Sawai Pharmaceutical Co Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Sawai Pharmaceutical Co Ltd including a breakdown and examination of key business segments

• News about Sawai Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Sawai Pharmaceutical Co Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Sawai Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Sawai Pharmaceutical Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Sumitomo Dainippon Pharma Co Ltd

Sosei Co Ltd

COSMOS Pharmaceutical Corporation

Chugai Pharmaceutical Co Ltd

ASKA Pharmaceutical Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sawai Pharmaceutical Co Ltd - Key Facts

Sawai Pharmaceutical Co Ltd - Key Employees

Sawai Pharmaceutical Co Ltd - Key Employee Biographies

Sawai Pharmaceutical Co Ltd - Major Products and Services

Sawai Pharmaceutical Co Ltd - History

Sawai Pharmaceutical Co Ltd - Company Statement

Sawai Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Sawai Pharmaceutical Co Ltd - Business Description

Geographical Segment: Japan

Performance

Geographical Segment: The US

Performance

Sawai Pharmaceutical Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Sawai Pharmaceutical Co Ltd - Strengths

Sawai Pharmaceutical Co Ltd - Weaknesses

Sawai Pharmaceutical Co Ltd - Opportunities

Sawai Pharmaceutical Co Ltd - Threats

Sawai Pharmaceutical Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020

Sawai Pharmaceutical Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 18, 2020: Sawai launches 14 generic drugs with 29 strengths

Feb 17, 2020: Sawai receives approvals for 15 generic drugs with 31 strengths

Jul 23, 2019: Sawai selected for FTSE4Good and FTSE Blossom Japan Indexes

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Sawai Pharmaceutical Co Ltd, Key Facts

Sawai Pharmaceutical Co Ltd, Key Employees

Sawai Pharmaceutical Co Ltd, Key Employee Biographies

Sawai Pharmaceutical Co Ltd, Major Products and Services

Sawai Pharmaceutical Co Ltd, History

Sawai Pharmaceutical Co Ltd, Subsidiaries

Sawai Pharmaceutical Co Ltd, Key Competitors

Sawai Pharmaceutical Co Ltd, Ratios based on current share price

Sawai Pharmaceutical Co Ltd, Annual Ratios

Sawai Pharmaceutical Co Ltd, Annual Ratios (Cont…1)

Sawai Pharmaceutical Co Ltd, Annual Ratios (Cont…2)

Sawai Pharmaceutical Co Ltd, Interim Ratios

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020

Sawai Pharmaceutical Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Sawai Pharmaceutical Co Ltd, Performance Chart (2016 – 2020)

Sawai Pharmaceutical Co Ltd, Ratio Charts

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020

Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports